December 17, 2010 — Dolasetron mesylate (Anzemet; Aventis Pharmaceuticals) should no longer be used for the prevention of chemotherapy-induced nausea and vomiting because of an increased risk for ...

Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person’s risk of stroke, heart failure and even premature death. While many risk factors contribute to A-fib, one stands ...

Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person’s risk of stroke, heart failure, and even premature death. While many risk factors contribute to A-fib, one stands ...

Q: What is the difference between atrial fibrillation and supraventricular tachycardia? A: While both conditions are rapid, abnormal heart rhythms that originate in the upper part of the heart, they ...

Using computers to make a digital replica of the heart -- a digital heart twin -- can successfully identify problem areas deep in the heart muscle of people with a serious heart rhythm disorder, a new ...

Heart attacks have become more survivable in the past 50 years, and are no longer the leading cause of heart disease-related deaths, a new study reports. As heart attack deaths fall, fatalities from ...

Sept 15 (Reuters) - U.S health regulators said they are reviewing the safety of GlaxoSmithKline's anti-nausea drug Zofran to ascertain whether there is a potential risk of abnormal hearth rhythm. The ...